Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-03-11 @ 4:43 PM
Study NCT ID:
NCT00808418
Status:
COMPLETED
Last Update Posted:
2014-02-03
First Post:
2008-12-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer
Sponsor:
Synta Pharmaceuticals Corp.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
4783-12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None